239 Health claim verifications avg. score 4.4/10 69 rated true or mostly true 169 rated false or misleading
“N-acetyl cysteine (NAC) supplementation is a proven cure or effective treatment for obsessive-compulsive disorder, bipolar disorder, and schizophrenia as of April 14, 2026.”
NAC has not been proven as a cure or effective treatment for OCD, bipolar disorder, or schizophrenia. Every high-authority peer-reviewed source describes NAC exclusively as an investigational adjunctive therapy with preliminary, mixed, or inconclusive results. No major regulatory authority — including the FDA, EMA, or WHO — has approved NAC for any of these three conditions. The largest NAC-OCD trial was still enrolling participants as of 2025, and researchers consistently call for additional large-scale trials before efficacy can be established.
“GHK-Cu delivers copper specifically to mitochondria, enhancing ATP production and cellular energy.”
No peer-reviewed evidence supports the assertion that GHK-Cu delivers copper specifically to mitochondria or directly enhances ATP production. The strongest biomedical sources show only that GHK-Cu modulates broad cellular copper uptake and gene expression, while mitochondrial copper import relies on dedicated chaperones (COX17, SLC25A3) with no demonstrated role for GHK-Cu. The explicit mitochondria/ATP claims trace back to marketing materials, YouTube videos, and wellness blogs — not controlled experiments or peer-reviewed research.
“The 'Community COVID Team' model in Vietnam, which involves local residents familiar with their area, has been effective in epidemiological surveillance, public communication, and social support during the COVID-19 pandemic.”
Vietnam's community-level COVID teams did perform epidemiological surveillance, public communication, and social support roles as described, with the World Bank explicitly documenting the model as "critical" in managing 40–50 household clusters. However, the claim overstates by implying consistent effectiveness across the entire pandemic. Evidence is strongest for early waves; during the 2021 Delta surge, community systems were overwhelmed, social support was largely inaccessible to informal workers, and local implementation failures were documented by UN and academic sources.
“A decline in Lactobacillus population in the urogenital microbiota is associated with an increased risk of urinary tract infections.”
Strong peer-reviewed evidence — including a 2023 meta-analysis and multiple comparative microbiome studies — consistently links reduced Lactobacillus abundance in the urogenital tract with higher UTI susceptibility. The claim's use of "associated with" accurately reflects the observational nature of the data. Minor caveats apply: the evidence is strongest in women with recurrent UTIs, causality versus correlation is not fully resolved, and in rare cases Lactobacillus itself can act as a uropathogen.
“Fast-digesting carbohydrates (simple carbs) are not necessary for human bodily function.”
The human body does not have a strict physiological requirement for fast-digesting (simple) carbohydrates specifically. While authoritative medical sources confirm that carbohydrates broadly are important for energy and brain function, none establish that simple carbs in particular — as distinct from complex carbs or endogenously produced glucose — are uniquely required. The body can generate glucose through gluconeogenesis from non-carbohydrate sources. However, the claim omits practical scenarios where fast-acting carbs are medically beneficial, such as treating hypoglycemia.
“Chitosan is widely used in the medical sector for wound healing and drug delivery systems due to its antimicrobial and biocompatible properties.”
Chitosan's use in wound healing and drug delivery is well-documented across peer-reviewed literature, with FDA-cleared wound dressings and a multi-billion-dollar market supporting the claim's core assertion. Multiple high-authority reviews explicitly link chitosan's antimicrobial and biocompatible properties to these applications. However, the claim slightly overstates the picture by omitting known limitations — low solubility at neutral pH and poor mechanical properties — that constrain some clinical applications and blur the line between extensive research activity and universal clinical deployment.
“Exclusion zone water forms on arterial walls and acts as an impenetrable barrier that prevents LDL cholesterol, red blood cells, and other large blood components from accessing the arterial endothelium.”
No credible scientific evidence supports the existence of an "impenetrable" exclusion zone water barrier on arterial walls that blocks LDL or red blood cells. Peer-reviewed vascular biology research consistently demonstrates that LDL reaches and crosses the arterial endothelium via transcytosis and paracellular transport — processes central to atherosclerosis. While exclusion zone phenomena have been observed near hydrophilic surfaces in laboratory settings, the mechanism remains disputed, and no study has demonstrated such a barrier in living arteries.
“Drinking warm water hydrates human cells more effectively than drinking cold water.”
No credible scientific evidence supports the assertion that warm water hydrates human cells more effectively than cold water. The only controlled human studies in the evidence pool found that cool (~16°C) water produced better overall hydration outcomes through higher voluntary intake and lower fluid losses. Claims favoring warm water rely on speculative mechanisms from non-peer-reviewed blogs and brand websites, none of which directly measured cellular hydration. Scientific consensus indicates water temperature has no meaningful effect on cellular hydration efficacy.
“Fear of public speaking, known as glossophobia, affects millions of people worldwide and can significantly limit personal growth.”
The core claim holds up well under scrutiny. Medical literature confirms that fear of public speaking affects roughly 15–30% of the global population, easily translating to hundreds of millions of people. The phrase "can significantly limit personal growth" is supported by documented evidence of avoidance behavior, missed career opportunities, and reduced participation — though this applies to a meaningful subset rather than all sufferers. The claim's careful use of "can" prevents it from being an overstatement, but it omits the fact that most people with this fear do not report significant daily impairment.
“Women who sleep naked next to their partners lose weight faster than women who sleep clothed in bed.”
No scientific study has ever tested whether women sleeping naked next to partners lose weight faster than those sleeping clothed. The claim stitches together unrelated findings — a five-man brown fat study, neonate skin-to-skin research, and general sleep-quality data — into a speculative chain that no evidence supports as a whole. Every credible medical source consulted explicitly states sleeping naked does not directly cause weight loss. The added detail about a partner's presence has zero basis in any published research.
“The FDA approved soy protein isolate at a daily intake of 25g despite its own safety committee recommending a maximum of 150mg per day.”
The central allegation — that an FDA safety committee recommended a 150mg/day maximum for soy protein isolate — is not supported by any FDA document, Federal Register entry, or peer-reviewed source in the evidentiary record. While the FDA did authorize a heart-health label claim tied to 25g/day of soy protein, and two individual FDA scientists raised concerns about isoflavone-related effects, no formal committee ever set a 150mg/day protein limit. The claim conflates milligram-range isoflavone discussions with gram-range protein intake and mischaracterizes individual dissent as an official committee recommendation.
“Doctronic, an AI company, is prescribing renewal medications to patients in Utah without physician involvement.”
Utah's Doctronic pilot is designed to eventually allow AI-driven prescription renewals without routine physician sign-off, but the claim significantly overstates current reality. As of early 2026, the program's active phase requires physician review of all renewals before they reach pharmacies. Even in later phases, escalation pathways to licensed physicians remain structurally embedded. The present-tense assertion of "no physician involvement" conflates the program's future autonomous design with its current operational requirements.
“Effective time management and maintaining positive social support networks are key strategies for university students to establish healthy boundaries between study, work, and rest.”
Strong peer-reviewed evidence supports both time management and social support as beneficial strategies for university students' wellbeing and stress reduction. Multiple systematic reviews and meta-analyses confirm these associations. However, the claim slightly overstates the evidence by framing these as strategies for "establishing healthy boundaries" specifically — the strongest empirical sources demonstrate wellbeing and stress outcomes rather than boundary-setting per se. The core practical message remains sound, but effect sizes for social support vary, and these strategies are not universally effective under heavy academic demands.
“Loss of smell (anosmia or olfactory dysfunction) is an early warning sign of Alzheimer's disease.”
Research consistently links olfactory decline to Alzheimer's-related biomarkers and future dementia risk, but the claim's framing overstates the connection. Smell loss is extremely common in normal aging, Parkinson's disease, Lewy body dementia, and many non-neurological conditions, making it far too nonspecific to serve as an Alzheimer's-specific warning sign. Major clinical authorities including the WHO and Mayo Clinic do not list it among primary early Alzheimer's symptoms. The evidence supports smell loss as a population-level risk indicator, not a reliable individual warning sign for Alzheimer's in particular.
“Loneliness is as harmful to human health as smoking 15 cigarettes per day.”
The comparison traces to a credible 2010 meta-analysis and was endorsed by the U.S. Surgeon General's 2023 Advisory, which states lacking social connection can increase premature death risk "as much as smoking up to 15 cigarettes a day." However, the claim drops the "up to" qualifier, conflates loneliness with broader social isolation, and presents a mortality-risk benchmark as a general health equivalence. At least one peer-reviewed cohort study found social isolation is actually less strongly linked to mortality than smoking, and a public health commentary warns the analogy oversimplifies the evidence.
“Fasting is not healthy for women who have high cortisol levels.”
While fasting does acutely raise cortisol and women show sex-specific changes in cortisol rhythm, the peer-reviewed evidence does not establish that fasting is clinically harmful for women with pre-existing high cortisol levels. The claim conflates a measurable hormonal response with demonstrated health harm—a logical leap unsupported by the highest-quality studies available. Sources making the stronger causal claim are predominantly wellness blogs and commercial health platforms, not clinical research on this specific population.
“Natural herbal remedies are inherently safer than pharmaceutical drugs.”
The scientific and medical evidence overwhelmingly contradicts the assertion that herbal remedies are "inherently safer" than pharmaceutical drugs. Multiple high-authority sources — including the NCCIH, WHO, Mayo Clinic, and numerous peer-reviewed systematic reviews — document serious adverse events from herbal products, including hepatotoxicity, renal failure, and death. The apparent safety record of herbal remedies largely reflects regulatory and surveillance gaps, not actual safety. No credible scientific authority endorses the premise that natural origin confers an inherent safety advantage.
“Chamomile tea has clinically demonstrated effects in reducing anxiety symptoms.”
Clinical trial evidence does support chamomile's anxiety-reducing effects, though the claim overstates the strength and scope of that evidence. A peer-reviewed, placebo-controlled trial found statistically significant reductions in anxiety scores, and a systematic review of 10 trials found 9 reporting positive results. However, most studies used standardized chamomile extract — not brewed tea — and effects are characterized as modest, primarily in mild-to-moderate generalized anxiety disorder. The claim is directionally accurate but lacks important qualifiers.
“Ginger is effective at reducing nausea in humans.”
Ginger's anti-nausea effect in humans is supported by a substantial body of evidence, though its strength varies by context. Multiple meta-analyses report statistically significant nausea reduction in pregnancy and postoperative settings, and ACOG endorses ginger as a first-line nonpharmacologic option for pregnancy nausea. However, evidence for chemotherapy-induced nausea in adults is weak or negative, and authoritative reviews (NCCIH, Cochrane) flag generally low-to-moderate evidence quality. The claim is directionally accurate but overstates the uniformity and certainty of the evidence.
“Lemon balm (Melissa officinalis) reduces anxiety and produces a calming effect on the nervous system.”
Multiple randomized, double-blind, placebo-controlled trials and a meta-analysis confirm that lemon balm supplementation can reduce anxiety and produce calming effects, supported by a well-characterized GABAergic mechanism. However, the claim is somewhat overstated: most positive trials used proprietary standardized extracts (e.g., Cyracos) in populations pre-selected for emotional distress or comorbid conditions, and the meta-analysis flagged high heterogeneity. The effect is real but mild compared to pharmaceutical anxiolytics, and results may not generalize to all lemon balm products or all populations.